Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,"Adalimumab, etanercept and secukinumab","Psoriatic arthritis, remove SA criteria relating to CRP","Adalimumab, etanercept and secukinumab",Options for investment,Community and Hospital,Oncology Agents and Immunosuppressants
